1. Recent advances in regenerative medicine strategies for cancer treatment
   Vahid Mansouri et al, 2021, Biomedicine & Pharmacotherapy CrossRef
2. Three year results of Blessed: Expanded access for DeltaRex-G for an intermediate size population with advanced pancreatic cancer and sarcoma (NCT04091295) and individual patient use of DeltaRex-G for solid malignancies (IND# 19130)
   Sant P. Chawla et al, 2022, Frontiers in Molecular Medicine CrossRef
3. Gene therapy in cancer
   Büşra Cesur‐Ergün et al, 2023, The Journal of Gene Medicine CrossRef
4. Actively targeted nanocarriers for drug delivery to cancer cells
   Stefania Biffi et al, 2019, Expert Opinion on Drug Delivery CrossRef
5. Ligand‐Installed Nanocarriers toward Precision Therapy
   Peng Mi et al, 2020, Advanced Materials CrossRef
6. A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer
   Sant P. Chawla et al, 2019, Molecular Therapy - Oncolytics CrossRef
7. Hybrid Nanostructures in Targeted Drug Delivery
   Gayatri Sharma et al, 2019, Hybrid Nanostructures for Cancer Theranostics CrossRef
8. Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy
   Ahmad Al-Shihabi et al, 2018, Molecular Therapy - Oncolytics CrossRef
9. Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting
   Hira Choudhury et al, 2019, International Journal of Pharmaceutics CrossRef
10. Gene Therapy in the Management of Parkinson’s Disease: Potential of GDNF as a Promising Therapeutic Strategy
    Tapan Behl et al, 2020, Current Gene Therapy CrossRef
11. Our Journey Beyond Sunset Boulevard: Evidence-Based Analysis of Tumor-Targeted Cancer Gene Therapy Shines a Critical Spotlight on Long-Term Cancer-Free Survival
    Frederick L. Hall et al, 2021, Our Journey Beyond Sunset Boulevard - Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on “True” Long-Term Cancer-Free Survival CrossRef
12. A para-aortic malignant melanotic nerve sheath tumor mimicking a gastrointestinal stromal tumor: a rare case report and review of literature
    Kuan-Yu Lin et al, 2022, BMC Surgery CrossRef
13. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead
    Md. Habban Akhter et al, 2021, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
14. Tunable metal–organic frameworks assist in catalyzing DNAzymes with amplification platforms for biomedical applications
    Xiaoguang Zhu et al, 2023, Chemical Society Reviews CrossRef
15. Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad‑spectrum cancer gene therapy - A review of molecular mechanisms for oncologists
    Erlinda Gordon et al, 2018, Molecular and Clinical Oncology CrossRef
16. The approved gene therapy drugs worldwide: from 1998 to 2019
    Cui-Cui Ma et al, 2020, Biotechnology Advances CrossRef
17. Challenges in development and authorisation of gene therapy products
    A. A. Soldatov et al, 2022, Biological Products. Prevention, Diagnosis, Treatment CrossRef
18. Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review
    Jack Gemayel et al, 2024, Advanced Genetics CrossRef
19. Gene Therapy Leaves a Vicious Cycle
    Reena Goswami et al, 2019, Frontiers in Oncology CrossRef
20. Case report: A rare case of massive peripheral nerve melanotic schwannoma and review of the literature
    Han Wang et al, 2023, Frontiers in Neurology CrossRef